Metastatic urothelial carcinoma: Is addition of more therapies to treatment regimens beneficial?


Shilpa Gupta, MD, discusses several recent studies in the metastatic urothelial carcinoma space.

In this video, Shilpa Gupta, MD, discusses how recent research appears to indicate that the addition of more agents is not beneficial to patients undergoing treatment for metastatic urothelial carcinoma. Gupta is the Director of the Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic.

Related Videos
Daniel J. Heidenberg, MD, answers a question during a Zoom video interview
African American patient explaining issues to Asian doctor using tablet | Image Credit: © rocketclips -
Todd M. Morgan, MD, answers a question during a Zoom video interview
3D illustration of prostate cancer cells | Image Credit: © Dr_Microbe -
Group of doctors reading a document | Image Credit: © Flamingo Images -
Blurred interior of hospital - abstract medical background | Image Credit: © jakkapan -
Related Content
© 2024 MJH Life Sciences

All rights reserved.